Physician profile
Ian Michael Foley
NPI 1801007109
$6,756.46
in general payments reported to CMS, 2019-2025
48 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $317 · 2021: $841 · 2022: $2,386 · 2023: $770 · 2024: $924 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,522 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,522.30 |
| Education | $268.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,330.77 | 2022-2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $759.34 | 2019-2025 | Veozah, Xtandi, Myrbetriq |
| Abbvie INC. | $665.00 | 2019-2023 | |
| Myovant Sciences INC. | $493.96 | 2021-2022 | |
| Pfizer INC. | $393.75 | 2021-2025 | |
| Exeltis, USA INC. | $357.40 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $355.55 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $214.47 | 2019-2022 | |
| Hologic Sales and Service, LLC | $212.73 | 2020-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $212.22 | 2022-2025 | |
| Coopersurgical, INC. | $175.26 | 2020-2025 | Paragard T 380a |
| Sage Therapeutics, LLC | $128.70 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $124.64 | 2019-2025 | |
| Minerva Surgical, INC | $113.24 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $94.97 | 2020-2024 | Gardasil 9, Gardasil |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $94.84 | 2023 | Arista Ah Flexitip |
| Organon LLC | $90.24 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $90.17 | 2020-2022 | |
| Shield Therapeutics INC | $79.38 | 2023-2024 | Accrufer |
| Channel Medsystems, INC. | $76.25 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $68.25 | 2022 | |
| Gynesonics, INC. | $55.43 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Avion Pharmaceuticals | $53.21 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $47.82 | 2021 | |
| Sanara Medtech INC. | $42.47 | 2025 | Celleraterx |
| Smith+Nephew, INC. | $39.16 | 2025 | Stravix |
| Evofem Biosciences, INC. | $33.83 | 2022 | |
| Agile Therapeutics, INC. | $32.02 | 2022 | |
| Convatec INC. | $25.39 | 2023 | |
| Daiichi Sankyo INC. | $24.50 | 2019-2021 | |
| Dexcom, INC. | $19.34 | 2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $18.48 | 2024 | Cologuard Collection Kit |
| Optumhealth Care Solutions, LLC | $17.82 | 2023 | Zyno Solutions, Vivify Health Care Team Portal |
| Millicent US INC | $17.06 | 2025 | Femlyv |
| Myriad Women'S Health, INC. | $17.00 | 2023 | Myrisk |
| Si-Bone, INC. | $16.57 | 2020 | |
| Lupin INC. | $16.31 | 2021 | |
| Novo Nordisk INC | $15.96 | 2023 | Wegovy |
| Lilly USA, LLC | $15.90 | 2025 | Zepbound |
| Radius Health, INC. | $14.69 | 2024 | Tymlos |
| Medicem INC. | $14.32 | 2025 | |
| Duchesnay USA Incorporated | $14.24 | 2019 | |
| Medtronic, INC. | $14.14 | 2025 | Ligasure |
| Vertical Pharmaceuticals, LLC | $13.92 | 2019 | |
| Amgen INC. | $12.92 | 2021 | |
| Meditrina | $10.96 | 2024 | |
| Allergan, INC. | $10.94 | 2019 | |
| Amag Pharmaceuticals, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Foley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.